SELL and Sepsis: Interestingly, anti-L-selectin antibody therapy in the present study did not adversely affect the 3 day mortality rate or the mean survival time, indicating that it had no overall adverse effects on the pathogenetic course of sepsis in this well established model of baboon sepsis [12].